太辰光 reported revenue of ¥1.00B for the period ended 2026-06-30, +20.8% year on year. Net income was ¥0.18B, a 18.2% net margin on a 34.8% gross margin. The largest revenue line is 光器件 at 96% of the total. Free cash flow for the period was ¥0.00B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.00B | +20.8% |
| Gross profit | ¥0.35B | — |
| Operating income | ¥0.19B | — |
| Net income | ¥0.18B | +3.2% |
| Gross margin | 34.8% | Net margin 18.2% |
| Revenue Q/Q | +93.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 光器件 | ¥0.96B | 95.8% |
| 其他 | ¥0.04B | 4.0% |
| 光传感 | ¥0.00B | 0.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.65B | 65.2% |
| R&D | ¥0.04B | 3.8% |
| SG&A | ¥0.06B | 6.4% |
| Tax & other | ¥0.01B | 1.2% |
| Item | Amount |
|---|---|
| Total assets | ¥2.71B |
| Total liabilities | ¥1.01B |
| Shareholders' equity | ¥1.70B |
| Equity / assets | 62.8% |
| Operating cash flow | ¥0.02B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥0.00B |
| Cash conversion (OCF / net income) | -40% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
平治信息 ・ 安车检测 ・ 兴齐眼药 ・ 中旗股份 ・ 容大感光 ・ 开润股份 ・ 会畅科技 ・ 数字认证 ・ 贝斯特 ・ 晨曦航空 ・ 英飞特 ・ 赛托生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies